Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VBIO Valion Bio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.51 -10.4% | $15.90 -2.5% |
| StockIQ Score | 48D+ Moderate Risk: High | 41D Weak Risk: High |
| Technical | 35F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 46D+ | 50C- |
| Fair Value | 55C | 38F |
| News | 86A | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Valion Bio (VBIO) scores higher overall, especially in fundamentals and valuation, with a 46 and 55 respectively, compared to Ascentage Pharma (AAPG), which has a 35 and 38. VBIO also has a stronger investor rating at "Moderate" versus AAPG’s "Weak." AAPG leads slightly in growth with a 50, but VBIO’s technical score (35) is marginally better than AAPG’s (36).
